20 results about "Dermal Fillers" patented technology

The present invention provides a composition for reducing or eliminating vascular occlusion caused by hyaluronic acid soft tissue dermal fillers. [Solution] This disclosure provides for compositions comprising hyaluronidase, apparatus for housing such compositions, and methods and uses of such compositions and apparatus for reducing or eliminating hyaluronic acid-induced blockages in one or more blood vessels supplying an individual's eye; methods and uses of such compositions and apparatus for reducing or inhibiting vascular occlusion of an individual's eye; and methods and uses of such compositions and apparatus for reducing or inhibiting hyaluronic acid-induced vision loss in an individual.

Provided herewith is a needle for delivering dermal filler thread to a wrinkle in a patient. The needle can also be used to deliver the thread to a patient for the purposes of facial contouring. The needle comprises a coupler for attaching the thread to the needle and also a trocar to ease delivery through the skin.

Introduced here are novel techniques and tools for augmenting the lips through superficial linear injection of dermal fillers. At a high level, these techniques are representative of a two-step approach to augmentation. In the first stage, an implement that is appropriately positioned inside a lip can be moved sideways—an action referred to as a “side push.” In the second stage, dermal filler can be ejected from the implement so as to fill the resulting void. These techniques can be used by healthcare professionals to reshape the lips for medical or aesthetic purposes. These techniques were developed in an attempt to permit augmentation of the outer surface of a lip so as to increase its volume by expanding sideways while turning the lip outward. Presented here are also tools to improve the accuracy of injection. With these techniques, the desired result-namely, a plumper lip—may be readily and consistently achievable.

Dermatological compositions comprising amphiphilic peptides, derivatives or salts thereof are provided. The compositions are particularly useful as dermal fillers and for inducing soft tissue repair and regeneration.

The present disclosure provides a method for reducing, removing, or dispersing a dermal filler aggregate in a subject. The method includes contacting a target area of the subject’s skin with a device configured to apply vibrational or mechanical energy, and applying vibrational energy to the target area for a duration sufficient to facilitate reduction, removal, or dispersion of the dermal filler aggregate. The vibrational energy may be applied while the device is held stationary over the aggregate or moved across the target area in vertical, horizontal, circular, or sweeping motions. In certain embodiments, the device is configured to contact the skin, and visible light is optionally applied during treatment. Application of vibrational energy promotes mechanical disruption and redistribution of dermal filler material within the surrounding tissue, thereby reducing the palpability or appearance of filler nodules, clumps, or irregularities.

The present invention relates to a dispersion comprising acellular dermal matrix microparticles, a filler comprising the same, and uses thereof. More specifically, the present invention relates to a filler comprising a dispersion containing acellular dermal matrix microparticles obtained by supercritical fluid extraction and high pressure dispersion operations, and a method for preparing the same. The acellular dermal filler according to the present invention has excellent biological stability and biocompatibility, and extracellular matrix components such as collagen and elastin are significantly preserved therein. In addition, the filling agent also shows excellent biochemical stability, the pH value or the collagen content and the elastin content are kept unchanged in the storage process, and the filling agent also shows physical stability and can continuously maintain injectability. Therefore, the acellular dermal filler can be effectively used as an injectable filler for repair or volume expansion of soft tissue and reduction of wrinkles in the field of plastic and regenerative medicine.

Hydrogels comprising a macromolecular matrix and water may be used for aesthetic fillers, for example, dermal fillers. The macromolecular matrix may include a crosslinked combination of hyaluronic acid and collagen.

1. Name of the product in this design: Vial (facial filler). 2. Purpose of this design: For packaging pharmaceuticals. 3. The key design features of this product are the combination of shape and pattern. 4. The image or photograph that best illustrates the design's key features: the front view.

The current invention involves a method of mixing POP with a polysaccharide to obtain an improved injectable tissue matrix. POP is a partially ordered polypeptide and a polysaccharide, in this instance, comprises at least one glycosaminoglycan. The invention involves mixing these compounds in an injectable tissue matrix to increase volume retention, vascularization, and remodeling immune response, all of which are characteristics that would be useful for an injectable dermal filler, and in plastic and reconstructive procedures.

Syringe attachments and syringes have particular suitability to the precision dispensing of small amounts of high viscosity materials, such as dermal fillers. An attachment may include a main body having an assist feature that includes a wheel and pinion gears on each side of the wheel which engage respective racks on the syringe body. A mechanical advantage may be provided to the user as the wheel is rotated relative to the syringe body and racks. Syringes and attachments may include precision position indicators viewed from multiple positions to enable a user to determine plunger position and the amount of dispensed contents with precision. An alternative configuration attachment may be slidably secured to a syringe to permit a user to operation the syringe from a lateral position using sliding movement of the thumb and fingers of one hand, for example. This configuration may be particularly suitable for self-administered insulin injections.

Provided herein are dermal fillers including decellularized plant or fungal tissue from which cellular materials and nucleic acids of the tissue are removed; as well as methods and uses thereof for cosmetic and / or reconstructive applications. Also provided are methods for preparing such dermal fillers, and dermal filler kits.

The invention provides a composition based on HA and HAp in the field of soft tissue filling and a preparation method thereof. Optionally, a dermal filler is used to increase facial tissue uplift by adding a volume to the facial tissue, correcting wrinkles and laws, and restoring the smooth appearance of the face. Optionally, the dermal filler includes an uncrosslinked or crosslinked HA that is chemically bonded to the HAp.

1. Name of the designed product: packaging box set (facial filler). 2. Use of the designed product: for packaging products. 3. Design points of the designed product: combination of shape and pattern. 4. Picture or photo best indicating the design points: perspective view of set 1. 5. Other circumstances needing explanation: set 1 is an outer box, and set 2 is an inner bottle.

This invention relates to an injectable dermal filler formulation for providing improved and uniform plumping and filling effects. Specifically, the formulation comprises a combination of hyaluronic acid and polyorthoesters and can be used for cosmetic purposes.

The present invention generally relates to the field of dermal fillers, and more specifically to a method for preparing a microparticles comprising crosslinked sulfated glycosaminoglycan (GAG) polysaccharide moieties. The present invention further relates to microparticles obtainable by said method and their use, as well as compositions comprising said microparticles and uses thereof.

A system and a method for delivering a dermal filler are illustrated. The system includes a dermal filler, wherein the dermal filler includes an injectable filler, wherein the injectable filler further includes at least a hyaluronic acid and at least a raw material, and a syringe configured to deliver the dermal filler. The method includes obtaining an injectable filler, wherein the injectable filler further comprises at least a hyaluronic acid, modifying the injectable filler by diluting the injectable filler using a raw material, and delivering the modified injectable filler by injecting the modified injectable filler into a patient using a syringe.

Provided herein are systems and methods for delivering to the tissue site a dermal filler formulation comprising a hydrogel that anneals in vivo to form a porous covalently stabilized scaffold under conditions sufficient to form a cell matrix within the porous covalently stabilized scaffold effective to permanently fill at least part of a tissue site of a subject with the cell matrix while minimizing a foreign body response in the subject.

To provide an improved dermal filler.SOLUTION: A dermal filler for improving the aesthetic quality of an anatomic feature of a human face by injection into the anatomic feature, contains a crosslinked macromolecular matrix containing lysine, hyaluronic acid, and collagen. The hyaluronic acid is crosslinked to the collagen by at least one endogenous amine group on the collagen and by at least one amine group present on the lysine.SELECTED DRAWING: None